Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-25 @ 7:35 PM
Study NCT ID:
NCT07249632
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-01
First Post:
2025-11-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
Sponsor:
RemeGen Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-18
First Submit QC Date:
None
Study First Post Date:
2025-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-27
Last Update Post Date:
2025-12-01
Last Update Post Date Type:
ESTIMATED